Experienced in Headache

Baba D. Inusa

Guy's And St. Thomas NHS Trust, 
London, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Headache
Guy's And St. Thomas NHS Trust, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Baba Inusa practices in London, United Kingdom. Inusa is rated as an Experienced expert by MediFind in the treatment of Headache. Their top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Adenoidectomy.

Their clinical research consists of co-authoring 101 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Headache.

Locations

Guy's And St. Thomas NHS Trust, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Study of Montelukast In ChiLdrEn With Sickle Cell Disease (SMILES)
Study of Montelukast In ChiLdrEn With Sickle Cell Disease (SMILES)
Enrollment Status: Recruiting
Publish Date: November 01, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2/Phase 3
A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease
A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: August 15, 2025
Intervention Type: Drug
Study Drug: Voxelotor
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Voxelotor (GBT440) in Pediatric Participants With Sickle Cell Disease (HOPE Kids 2)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Voxelotor (GBT440) in Pediatric Participants With Sickle Cell Disease (HOPE Kids 2)
Enrollment Status: Terminated
Publish Date: June 13, 2025
Intervention Type: Drug
Study Drug: Voxelotor
Study Phase: Phase 3
The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias
The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias
Enrollment Status: Terminated
Publish Date: August 10, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

101 Total Publications

Treating sickle cell disease in resource-limited sub-saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidenced based management.
Treating sickle cell disease in resource-limited sub-saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidenced based management.
Journal: Expert review of hematology
Published: May 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Inusa's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile